 |
|
Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
Linda L. Wong, Ruel J. Reyes, Sandi A. Kwee, Brenda Y. Hernandez, Sumodh C. Kalathil, Naoky C. Tsai
Clin Mol Hepatol. 2017;23(3):239-248. Published online 2017 Jul 14 DOI: https://doi.org/10.3350/cmh.2017.0008
|
|
Citations to this article as recorded by
 Proper assessment and prognostication of patients with hepatocellular carcinoma
Edoardo G. Giannini
Clinical Liver Disease.2024;[Epub] CrossRef Detecting Early Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Using Longitudinal α-Fetoprotein Screening
Jonggi Choi, Nabihah Tayob, Young-Suk Lim
Clinical Gastroenterology and Hepatology.2023; 21(6): 1590. CrossRef Development and prognosis of hepatocellular carcinoma in patients with diabetes
Takuma Nakatsuka, Ryosuke Tateishi
Clinical and Molecular Hepatology.2023; 29(1): 51. CrossRef Magnetic Resonance Imaging-Based Surveillance of Hepatocellular Carcinoma: Current Status and Future Perspectives
Hyo Jung Park, So Yeon Kim, Young-Suk Lim
Current Hepatology Reports.2023; 22(3): 83. CrossRef Screening of liver cancer with abbreviated MRI
Maxime Ronot, Pierre Nahon, Jordi Rimola
Hepatology.2023; 78(2): 670. CrossRef From NAFLD to HCC: Advances in noninvasive diagnosis
Qinchen Xu, Maoxiao Feng, Yidan Ren, Xiaoyan Liu, Huiru Gao, Zigan Li, Xin Su, Qin Wang, Yunshan Wang
Biomedicine & Pharmacotherapy.2023; 165: 115028. CrossRef Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high‐risk patients
Hyo Jung Park, So Yeon Kim, Amit G. Singal, So Jung Lee, Hyung Jin Won, Jae Ho Byun, Sang Hyun Choi, Takeshi Yokoo, Min‐Ju Kim, Young‐Suk Lim
Liver International.2022; 42(9): 2080. CrossRef A multi‐analyte cell‐free DNA–based blood test for early detection of hepatocellular carcinoma
Nan Lin, Yongping Lin, Jianfeng Xu, Dan Liu, Diange Li, Hongyu Meng, Maxime A. Gallant, Naoto Kubota, Dhruvajyoti Roy, Jason S. Li, Emmanuel C. Gorospe, Morris Sherman, Robert G. Gish, Ghassan K. Abou‐Alfa, Mindie H. Nguyen, David J. Taggart, Richard A. V
Hepatology Communications.2022; 6(7): 1753. CrossRef Current Landscape and Future Perspectives of Abbreviated MRI for Hepatocellular Carcinoma Surveillance
Hyo Jung Park, Nieun Seo, So Yeon Kim
Korean Journal of Radiology.2022; 23(6): 598. CrossRef Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)
Thierry de Baere, Maxime Ronot, Jin Wook Chung, Rita Golfieri, Roman Kloeckner, Joong-Won Park, Bernhard Gebauer, Nabil Kibriya, Ganapathy Ananthakrishnan, Shiro Miyayama
CardioVascular and Interventional Radiology.2022; 45(10): 1430. CrossRef Spontaneous Regression of Hepatocellular Carcinoma From Autoinfarction and Implications on Liver Transplantation
Kevin Singh
ACG Case Reports Journal.2022; 9(7): e00825. CrossRef Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance
Junghwan Lee, Su Bee Park, Soyoung Byun, Ha Il Kim, Do Young Kim
PLOS ONE.2022; 17(9): e0274747. CrossRef Current status of disparity in liver disease
Tomoki Sempokuya, Josh Warner, Muaataz Azawi, Akane Nogimura, Linda L Wong
World Journal of Hepatology.2022; 14(11): 1940. CrossRef Pathogenesis to management of hepatocellular carcinoma
Ben L. Da, Aiwu Ruth He, Kirti Shetty, Kelly I. Suchman, Herbert Yu, Lawrence Lau, Linda L. Wong, Atoosa Rabiee, Richard L. Amdur, James M. Crawford, Sharon S. Fox, Gregory M. Grimaldi, Priya K. Shah, Jonathan Weinstein, David Bernstein, Sanjaya K. Satapa
Genes & Cancer.2022; 13: 72. CrossRef Current status of image-based surveillance in hepatocellular carcinoma
Dong Hwan Kim, Joon-Il Choi
Ultrasonography.2021; 40(1): 45. CrossRef Failure in all steps of hepatocellular carcinoma surveillance process is frequent in daily practice
Melisa Dirchwolf, Sebastián Marciano, Andres E. Ruf, Amit G. Singal, Vanina D'Ercole, Paola Coisson, Alina Zerega, Federico Orozco, Ana Palazzo, Eduardo Fassio, Diego Arufe, Margarita Anders, Claudia D'Amico, Luis Gaite, Marcos Thompson, Daniela Perez, Le
Annals of Hepatology.2021; 25: 100344. CrossRef Diagnostic Performance of Simulated Abbreviated MRI for Early-Stage Hepatocellular Carcinoma Screening: A Comparison to Conventional Dynamic Contrast-Enhanced MRI
Eun Sol Lim, Sung Mo Kim, Sang Soo Shin, Suk Hee Heo, Jong Eun Lee, Yong Yeon Jeong
Journal of the Korean Society of Radiology.2021; 82(5): 1218. CrossRef A Systematic Review and Narrative Synthesis of Health Economic Evaluations of Hepatocellular Carcinoma Screening Strategies
Anh Le Tuan Nguyen, Hoa Thi Thu Nguyen, Kwang Chien Yee, Andrew J. Palmer, Christopher Leigh Blizzard, Barbara de Graaff
Value in Health.2021; 24(5): 733. CrossRef The APAC Score: A Novel and Highly Performant Serological Tool for Early Diagnosis of Hepatocellular Carcinoma in Patients with Liver Cirrhosis
Joeri Lambrecht, Mustafa Porsch-Özçürümez, Jan Best, Fabian Jost-Brinkmann, Christoph Roderburg, Münevver Demir, Frank Tacke, Raphael Mohr
Journal of Clinical Medicine.2021; 10(15): 3392. CrossRef Reply to: “Comment on – A multi-center study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in the Republic of Korea”
Beom Kyung Kim
Journal of Hepatology.2020; 72(1): 198. CrossRef Only one-third of hepatocellular carcinoma cases are diagnosed via screening or surveillance: a systematic review and meta-analysis
Changqing Zhao, Feng Xing, Yee Hui Yeo, Michelle Jin, Richard Le, Michael Le, Mingjuan Jin, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
European Journal of Gastroenterology & Hepatology.2020; 32(3): 406. CrossRef GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
Jan Best, Lars P. Bechmann, Jan-Peter Sowa, Svenja Sydor, Alexander Dechêne, Kristina Pflanz, Sotiria Bedreli, Clemens Schotten, Andreas Geier, Thomas Berg, Janett Fischer, Arndt Vogel, Heike Bantel, Arndt Weinmann, Jörn M. Schattenberg, Yvonne Huber, Hen
Clinical Gastroenterology and Hepatology.2020; 18(3): 728. CrossRef Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma
Christopher Welberry, Isabel Macdonald, Jane McElveen, Celine Parsy-Kowalska, Jared Allen, Graham Healey, William Irving, Andrea Murray, Caroline Chapman, Vasilis Kosmoliaptsis
PLOS ONE.2020; 15(5): e0232247. CrossRef Exosomal microRNA‐4661‐5p–based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinoma
Hyo Jung Cho, Geum Ok Baek, Chul Won Seo, Hye Ri Ahn, Suna Sung, Ju A Son, Soon Sun Kim, Sung Won Cho, Jeong Won Jang, Suk Woo Nam, Jae Youn Cheong, Jung Woo Eun
Cancer Medicine.2020; 9(15): 5459. CrossRef Is hepatocellular carcinoma surveillance in high-risk populations effective?
Kristeen Onyirioha, Sukul Mittal, Amit G Singal
Hepatic Oncology.2020;[Epub] CrossRef Imaging Modalities for Hepatocellular Carcinoma Surveillance: Expanding Horizons beyond Ultrasound
Hyo Jung Park, So Yeon Kim
Journal of Liver Cancer.2020; 20(2): 99. CrossRef Abbreviated MRI for Hepatocellular Carcinoma Screening and Surveillance
Julie Y. An, Miguel A. Peña, Guilherme M. Cunha, Michael T. Booker, Bachir Taouli, Takeshi Yokoo, Claude B. Sirlin, Kathryn J. Fowler
RadioGraphics.2020; 40(7): 1916. CrossRef Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma
Jung Hee Son, Sang Hyun Choi, So Yeon Kim, Hye Young Jang, Jae Ho Byun, Hyung Jin Won, So Jung Lee, Young Suk Lim
Radiology.2019; 292(2): 390. CrossRef Failure of hepatocellular carcinoma surveillance: inadequate echogenic window and macronodular parenchyma as potential culprits
Yeun-Yoon Kim, Chansik An, Do Young Kim, Khalid Suliman Aljoqiman, Jin-Young Choi, Myeong-Jin Kim
Ultrasonography.2019; 38(4): 311. CrossRef Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis
Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han, Do Young Kim
Scandinavian Journal of Gastroenterology.2019; 54(10): 1283. CrossRef Risk factors for biopsy‐proven advanced non‐alcoholic fatty liver disease in the Veterans Health Administration
Y. A. Patel, E. J. Gifford, L. M. Glass, R. McNeil, M. J. Turner, B. Han, D. Provenzale, S. S. Choi, C. A. Moylan, C. M. Hunt
Alimentary Pharmacology & Therapeutics.2018; 47(2): 268. CrossRef Diffusion-weighted MRI as a screening tool for hepatocellular carcinoma in cirrhotic livers: correlation with explant data—a pilot study
M. M. McNamara, J. V. Thomas, L. F. Alexander, M. D. Little, D. N. Bolus, Yufeng E. Li, D. E. Morgan
Abdominal Radiology.2018; 43(10): 2686. CrossRef Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?
Kwang Min Kim, Jiyu Kim, Dong Hyun Sinn, Hye Seung Kim, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scandinavian Journal of Gastroenterology.2018; 53(6): 727. CrossRef Surveillance of hepatocellular carcinoma: is only ultrasound enough?
Woo Kyoung Jeong
Clinical and Molecular Hepatology.2017; 23(3): 222. CrossRef
|